SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SangStat Med. (SANG) - 10 of 10 analysts say Strong Buy
SANG 4.950+2.1%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: kendall harmon who wrote (177)5/11/1999 11:50:00 PM
From: Richard Haugland  Read Replies (1) of 184
 
Amazing how these posts come back to haunt you. In the months since H&Q made this recommendation they changed their mind and downgraded SANG just when they started to move past $16 and the stock gets hit back to 11 1/2 in 1 day. Now SANG announces an agreement to market their cyclosporin through Abbott and SANG moves up again to a 15 1/16 close today.

I'll make the prediction that when someone again posts on this almost dead board in 2-3 months SANG will be back above $20. IMHO, the deal with Abbott gives SANG the leverage and clout to deal with the bullies in this field and makes a lot of sense.

Thanks to H&Q for the opportunity to buy more SANG below $13.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext